Literature DB >> 8208269

Diabetes and the risk of pancreatic cancer.

L Gullo1, R Pezzilli, A M Morselli-Labate.   

Abstract

BACKGROUND: Diabetes and pancreatic cancer are known to be associated, but the cause of the association and whether diabetes is a risk factor for pancreatic cancer remain controversial.
METHODS: A total of 720 patients with pancreatic cancer and 720 control patients from 14 Italian centers were enrolled in the study. All subjects were interviewed personally and in detail about their clinical history. The diagnosis of diabetes was based on criteria recommended by the American Diabetes Association.
RESULTS: One hundred sixty-four patients with pancreatic cancer (22.8 percent) and 60 controls (8.3 percent) had diabetes. In the majority of the patients with pancreatic cancer (56.1 percent), diabetes was diagnosed either concomitantly with the cancer (in 40.2 percent), or within two years before the diagnosis of cancer (in 15.9 percent). The association between the two conditions was significant (odds ratio, 3.04; 95 percent confidence interval, 2.21 to 4.17). However, when only patients with diabetes of three or more years' duration were considered, the association was no longer significant (odds ratio, 1.43; 95 percent confidence interval, 0.98 to 2.07). All the patients with pancreatic cancer whose diabetes had been diagnosed before the cancer had non-insulin-dependent diabetes; all but one of the control patients with diabetes had the non-insulin-dependent form of the disease.
CONCLUSIONS: Diabetes in patients with pancreatic cancer is frequently of recent onset and is presumably caused by the tumor. Diabetes is not a risk factor for pancreatic cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8208269     DOI: 10.1056/NEJM199407143310203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  74 in total

1.  Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group.

Authors:  M Soler; N Malats; M Porta; E Fernandez; L Guarner; A Maguire; J L Pinõl; J Rifà; A Carrato
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 4.  Detecting early pancreatic cancer: problems and prospects.

Authors:  Suresh T Chari
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

5.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines.

Authors:  F Wang; J Larsson; A Abdiu; T Gasslander; P Westermark; T E Adrian; J Permert
Journal:  Int J Pancreatol       Date:  1997-04

7.  High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.

Authors:  Sarah A Bannon; Maria F Montiel; Jennifer B Goldstein; Wenli Dong; Maureen E Mork; Ester Borras; Merve Hasanov; Gauri R Varadhachary; Anirban Maitra; Matthew H Katz; Lei Feng; Andrew Futreal; David R Fogelman; Eduardo Vilar; Florencia McAllister
Journal:  Cancer Prev Res (Phila)       Date:  2018-10-01

Review 8.  Diabetes mellitus: a risk factor for pancreatic cancer?

Authors:  M Yalniz; P M Pour
Journal:  Langenbecks Arch Surg       Date:  2004-04-09       Impact factor: 3.445

9.  Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen; Suresh T Chari
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

10.  Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.

Authors:  Evan J Walker; Andrew H Ko; Elizabeth A Holly; Paige M Bracci
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.